[109604] in Cypherpunks
Bridge Technology Initiates Coverage on ORTC and CBST
daemon@ATHENA.MIT.EDU (info@bridgenyc.com)
Tue Mar 30 18:01:39 1999
From: info@bridgenyc.com
To: <cypherpunks@algebra.com>
Date: Tue, 30 Mar 1999 14:11:30
Reply-To: info@bridgenyc.com
Bridge Technology Group recently initiated research coverage on
two healthcare companies:
Ortec International, (Nasdaq: ORTC), a company in late-stage
development of a unique wound-healing/skin replacement product
expected to be on the market by the end of the year;
and Cubist Pharmaceuticals (Nasdaq: CBST), an anti-infectives
company with a novel antibiotic product in Phase III clinical
trials and an early-stage genomics technology that accelerates the
discovery of novel anti-infective targets.
Please visit our website at www.BridgeNYC.com for downloadable and
scrollable versions of the reports. As always, you do not need to
register to enter the web site.
Please let us know if you have any comments or questions or if you
would like to be removed from this mailing list. N.B.: we do not
sell, barter or disclose this list to anyone.
------------
Bridge Technology Group LLC is a registered investor advisor (NY
State) and is focused on identifying emerging growth companies in
the healthcare and information technology sectors that offer
compelling investment opportunities over the long term. By
providing comprehensive financial services, including corporate
finance, M&A advisory, strategic partnering and communications
consulting, the company positions itself to provide a fully
integrated package of value-added services to emerging growth
companies.
